CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Tyrer, Peter ^a   Cooper, Sylvia ^a   Tyrer, Helen ^a   Salkovskis, Paul ^b   Crawford, Mike ^a   Green, John ^c   Smith, Georgina ^c   Reid, Steven ^c   Dupont, Simon ^d   Murphy, David ^e   Byford, Sarah ^f   Wang, Duolao ^g   Barrett, Barbara ^f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b University of Bath   (United Kingdom)

^c CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d HILLINGDON HOSPITAL   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROFESSIONAL COMPETENCE; RANDOMIZED CONTROLLED TRIAL; REASSURANCE; SALKOVSKIS WARWICK MODEL; ADOLESCENT; AGED; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; MALE; METHODOLOGY; MIDDLE AGED; PERSONALITY TEST; STATISTICS;

ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOLS; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; PERSONALITY ASSESSMENT;

EID: 79958278836     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-99     Document Type: Article

References (34)

1. Robbins JM, Kirmayer LJ. Transient and persistent hypochondriacal worry in primary care. Psychol Med 1996, 26:575-89. 10.1017/S0033291700035650, 8733216.
2. Barsky AJ, Wyshak G, Klerman GL, Latham KS. The prevalence of hypochondriasis in medical outpatients. Soc Psychiat Psychiatric Epidem 1990, 25:89-94.
3. Escobar JI, Gara M, Waitzkin H, Silver RC, Holman A, Compton W. DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry 1998, 20:155-9. 10.1016/S0163-8343(98)00018-8, 9650033.
4. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005, 62:903-10. 10.1001/archpsyc.62.8.903, 16061768.
5. Seivewright H, Salkovskis P, Green J, Mullan N, Behr G, Carlin E, Young S, Goldmeier D, Tyrer P. Prevalence and service implications of health anxiety in genitourinary medicine clinics. Int J STD & AIDS 2004, 15:519-22.
6. Seivewright H, Mulder R, Tyrer P. Prevalence of health anxiety and medically unexplained symptoms in general practice and hospital clinics. Aust N Z J Psychiatry 2007, 41(suppl 2):A159.
7. Rode S, Salkovskis P, Dowd H, Hanna M. Health anxiety levels in chronic pain clinic attenders. J Psychosom Res 2006, 60:155-61. 10.1016/j.jpsychores.2005.07.005, 16439268.
8. Clark DM, Salkovskis PM, Hackmann A, Wells A, Fennell M, Ludgate, Ahmad S, Richards HC, Gelder M. Two psychological treatments for hypochondriasis: a randomized controlled trial. Br J Psychiatry 1998, 173:218-225. 10.1192/bjp.173.3.218, 9926097.
9. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA 2004, 292:1464-70.
10. Seivewright H, Green J, Salkovskis P, Barrett B, Nur U, Tyrer P. Randomised controlled trial of cognitive behaviour therapy in the treatment of health anxiety in a genitourinary medicine clinic. Br J Psychiatry 2008, 192:332-337. 10.1192/bjp.192.5.332, 18450654.
11. Salkovskis PM, Warwick HM. Morbid preoccupations, health anxiety and reassurance: a cognitive-behavioural approach to hypochondriasis. Behav Res Ther 1986, 24:597-602. 10.1016/0005-7967(86)90041-0, 3753387.
12. Warwick HM. A cognitive-behavioural approach to hypochondriasis and health anxiety. J Psychosom Res 1989, 33:705-711. 10.1016/0022-3999(89)90086-X, 2621674.
13. Salkovskis PM, Rimes KA, Warwick HMC, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002, 32:843-853.
14. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983, 57:361-70.
15. EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQol Group.
16. Tyrer P, Nur U, Crawford M, Karlsen S, McLean C, Rao B, Johnson T. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. Int J Soc Psychiatr 2005, 51:265-275.
17. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for the DSM-IV Axis I Disorders 1996, Washington DC: American Psychiatric Press.
18. Uher R, Heyman I, Mortimore C, Frampton I, Goodman R. Screening young people for obsessive-compulsive disorder. Br J Psychiatry 2007, 191:353-4. 10.1192/bjp.bp.106.034967, 17906247.
19. Tyrer P, Morgan J, Cicchetti D. The Dependent Personality Questionnaire (DPQ): a screening instrument for dependent personality. Int J Soc Psychiatr 2004, 50:10-17.
20. Tyrer P, Alexander MS, Cicchetti D, Cohen MS, Remington M. Reliability of a schedule for rating personality disorders. Br J Psychiatry 1979, 135:168-174. 10.1192/bjp.135.2.168, 497620.
21. Tyrer P. Quick Personality Assessment Schedule: PAS-Q. Personality Disorders: Diagnosis, Management and Course 2000, 181-190. London: Arnold, Tyrer P, 2.
22. Barrett B, Byford S, Crawford M, Patton R, Drummond C, Henry J, Touquet R. Cost-effectiveness of referral to an alcohol health worker in patients attending an accident and emergency department: a decision-making approach. Drug Alcohol Depend 2006, 81:47-54. 10.1016/j.drugalcdep.2005.05.015, 16006055.
23. Byford S, Fiander M, Torgerson DJ, Barber JA, Thompson SG, Burns T, van Horn E, Gilvarry C, Creed F. Cost-effectiveness of intensive v. standard case management for severe psychotic illness: UK700 case management trial. Br J Psychiatry 2000, 176:537-543. 10.1192/bjp.176.6.537, 10974959.
24. Kessler RC. The World Health Organization Health and Work Performance Questionnaire (HPQ) 2003, WHO, Geneva.
25. Young J, Beck AT. Cognitive Therapy Scale Rating Manual 1980, Psychotherapy Research Unit, University of Pennsylvania, Philadelphia, USA.
26. Davidson K, Scott J, Schmidt U, Tata P, Thornton S, Tyrer P. Therapist competence and clinical outcome in the Prevention of Parasuicide by Manual Assisted Cognitive Behaviour Therapy Trial: the POPMACT study. Psychol Med 2004, 34:855-863. 10.1017/S0033291703001855, 15500306.
27. Kingdon D, Tyrer P, Seivewright N, Ferguson B, Murphy S. The Nottingham Study of Neurotic Disorder: influence of cognitive therapists on outcome. Br J Psychiatry 1996, 169:93-97. 10.1192/bjp.169.1.93, 8818375.
28. National Institute for Health and Clinical Excellence Methods for technology appraisal 2008, NICE, London, National Institute for Health and Clinical Excellence.
29. Briggs AH, O'Brien BJ. The death of cost-minimization analysis?. Health Econ 2001, 10:179-184. 10.1002/hec.584, 11252048.
30. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001, 10:779-787. 10.1002/hec.635, 11747057.
31. Bosmans JE, de Bruijne MC, van Hout HPJ, Hermens MLM, Adèr HJ, van Tulder MW. Practical guidelines for economic evaluations alongside equivalence trials. Value in Health 2008, 11:251-258. 10.1111/j.1524-4733.2007.00245.x, 18380637.
32. Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial. Health Technol Ass 2006, 10:1-67.
33. Hedman E, Andersson G, Andersson E, Ljótsson B, Rück C, Asmundson GJG, Lindefors N. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. BrJ Psychiatry 2011, 198:230-236.
34. Tyrer H, Tyrer P, Lovett I. Adapted cognitive-behavior therapy for medically unexplained symptoms in secondary care reduces hospital contacts. Psychosomatics 2011, 52:194-197.